December 4, 2012

Dissecting Evolving Claims Against Generic Drugs and the Naming of Brand Manufacturers as Co-Defendants

ACI 17th Annual Drug & Medical Device Litigation Conference

Overview

Chicago partner David Sudzus will speak at the American Conference Institute’s 17th Annual Drug & Medical Device Litigation Conference on Tuesday, December 4 in New York City.

Dave, a partner in the the Products Liability & Mass Tort Practice Group, will speak on a panel titled, "Dissecting Evolving Claims Against Generic Drugs and the Naming of Brand Manufacturers as Co-Defendants.”

The panel will discuss:

  • Strategies for responding as co-defendants when both brand and generic manufacturers are cited in a complaint.
  • When disunion on the defense side can lead to bad results.
  • Working cooperatively under a joint defense agreement.
  • Presenting a united front on warning, testing and other issues.
  • Current pharmacovigilance requirements for generics vs. conduct required of brand manufacturers.
  • Understanding the duty of care to generic drug users whose doctors foreseeably relied on the brand-name manufacturer’s product information.
  • Crafting an adequate label and ensuring that its warnings remain adequate.
  • Relying on scientific literature and medical science in evaluating whether the drug generally could cause the injury alleged.

Services and Industries

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.